Eprex Injection 10,000 IU contains Erythropoietin Alfa, a recombinant form of human erythropoietin. It is primarily used to stimulate red blood cell production in patients with anemia associated with chronic kidney disease, chemotherapy, or other medical conditions leading to reduced erythropoietin levels. By increasing the number of red blood cells, Eprex Injection helps improve oxygen delivery to tissues, reduce fatigue, and enhance overall quality of life.
Anemia is a condition marked by a decrease in red blood cells or hemoglobin, leading to symptoms such as weakness, pallor, shortness of breath, and reduced physical performance. In patients with chronic kidney disease or undergoing chemotherapy, the body’s natural production of erythropoietin may be insufficient, resulting in anemia. Eprex Injection provides a reliable and effective solution by replacing or supplementing the body’s erythropoietin, promoting normal red blood cell formation.
This high-potency 10,000 IU formulation is suitable for adults and pediatric patients under careful medical supervision. It is administered subcutaneously or intravenously, depending on clinical requirements, and dosing is individualized based on hemoglobin levels and patient response.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient:
Erythropoietin Alfa 10,000 IU per injection
Effective Anemia Management:
Stimulates red blood cell production
Increases hemoglobin and hematocrit levels
Reduces fatigue and improves physical performance
Wide Therapeutic Application:
Anemia due to chronic kidney disease
Anemia associated with chemotherapy
Other conditions requiring erythropoietin supplementation
Convenient Administration:
Can be given subcutaneously or intravenously
High-potency dose suitable for individualized therapy
Supports maintenance of optimal hemoglobin levels
Erythropoietin Alfa is a glycoprotein that mimics the action of naturally occurring erythropoietin, which is produced in the kidneys. It binds to erythropoietin receptors in the bone marrow, stimulating the proliferation and differentiation of red blood cell precursors. This process increases the production of mature red blood cells, improving oxygen transport throughout the body and alleviating symptoms of anemia.
Unlike conventional blood transfusions, Eprex Injection supports the body’s own ability to produce red blood cells, reducing dependency on repeated transfusions and associated complications.
Eprex Injection 10,000 IU is indicated for:
Anemia associated with chronic kidney disease, including patients on dialysis
Chemotherapy-induced anemia in cancer patients
Reduction of the need for allogeneic blood transfusions in surgical patients with non-cardiac procedures
Other conditions leading to insufficient endogenous erythropoietin production
Administer subcutaneously or intravenously as directed by a physician.
Dose is individualized according to hemoglobin levels, body weight, and clinical response.
Monitor hemoglobin and hematocrit regularly to avoid excessive red blood cell production.
Typically given 1–3 times per week, but frequency may vary based on patient condition.
Do not adjust the dose without medical guidance. Abrupt discontinuation or misuse may lead to inadequate treatment or adverse effects.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Monitor blood pressure, as hypertension may occur during therapy.
Inform the doctor of any history of cardiovascular disease, stroke, or clotting disorders.
Common side effects include headache, hypertension, joint pain, and injection site reactions.
Rarely, severe allergic reactions, blood clots, or pure red cell aplasia may occur. Seek immediate medical attention if serious adverse events develop.
Use with caution in patients with pre-existing cardiovascular risk factors.
Store in a refrigerator at 2–8°C.
Do not freeze.
Protect from light and agitation.
Keep out of reach of children.
Eprex Injection 10,000 IU offers an effective and clinically proven therapy for managing anemia, supporting red blood cell production, and improving quality of life for patients with chronic kidney disease, chemotherapy-related anemia, or other conditions requiring erythropoietin supplementation.
Login Or Registerto submit your questions to seller
No none asked to seller yet